Jonathan has led numerous business enterprise valuation, purchase price allocation, intangible asset valuation, estate and gift tax valuation and tax restructuring engagements. His industry experience includes prescription pharmaceuticals, generic pharmaceuticals, healthcare services, medical devices, consumer products, technology, and others.
Jonathan's engagement highlights include purchase price allocations for multi-national corporations and private equity firms, legal entity valuations for multi-national corporations in connection with operational restructuring, and goodwill impairment testing related valuations for numerous healthcare and non-healthcare clients.
Jonathan joined Kroll as a senior associate in 2006. Jonathan received his M.B.A. in finance and accounting from the Fordham Graduate School of Business and B.A.s in economics and philosophy from Boston College in Chestnut Hill, MA.
